Journal of Nursing ›› 2024, Vol. 31 ›› Issue (20): 67-72.doi: 10.16460/j.issn1008-9969.2024.20.067
Previous Articles Next Articles
Current status of depression and anxiety in newly diagnosed nasopharyngeal carcinoma patients and their relationship with fear of disease progression
QI Li-ping1a, WANG Wen-xuan2, HOU Min1a, ZHENG Yue-hao1a, FENG Hui-xia1a, LI Ji-bin1b,3,4
- 1a. Dept. of Radiotherapy; 1b. Dept. of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China;
2. School of Public Health, Sun Yat-sen University, Guangzhou 510080, China;
3. State Key Laboratory of Oncology in South China, Guangzhou 510060, China;
4. Guangdong Provincial Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,Guangzhou 510060, China
CLC Number:
- R473.76
| [1] Zhang Y, Rumgay H, Li M, et al.Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling[J]. JMIR Public Health Surveill, 2023,9:e49968. DOI: 10.2196/49968. [2] 邱丽燕, 杨丽, 廖婷婷, 等. 鼻咽癌出院5年患者症状群与生活质量的相关性研究[J]. 护理学杂志, 2021,36(3):38-41. DOI:10.3870/j.issn.1001-4152.2021.03.038. [3] McDowell LJ, Rock K, Xu W, et al. Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2018,102(2):340-352.DOI: 10.1016/j.ijrobp.2018.05.060. [4] 李颖斐, 刘玉瑶, 魏洁丽, 等. 鼻咽癌患者癌症复发恐惧水平及影响因素分析[J]. 中华全科医学, 2019,17(9):1443-1446.DOI:10.16766/j.cnki.issn.1674-4152.000965. [5] 马飞飞,彭鹏,劳家辉,等. 基于SEER数据库分析癌症患者自杀率的长期趋势[J]. 中华肿瘤防治杂志, 2022,29(4):248-252. DOI:10.16073/j.cnki.cjcpt.2022.04.03. [6] Kroenke K, Spitzer RL, Williams JB.The PHQ-9: validity of a brief depression severity measure[J]. J Gen Intern Med, 2001,16(9):606-613.DOI:10.1046/j.1525-1497.2001.016009606.x. [7] 闵宝权, 周爱红, 梁丰, 等. 病人健康问卷抑郁自评量表(PHQ-9)的临床应用[J]. 神经疾病与精神卫生, 2013,13(6):569-572. DOI:10.3969/j.issn.1009-6574.2013.06.009. [8] Garcia-Campayo J, Zamorano E, Ruiz MA, et al.Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool[J]. Health Qual Life Outcomes, 2010,8:8. DOI: 10.1186/1477-7525-8-8. [9] 吕兰竹, 周月英, 苏泳诗. GAD-7和PHQ-9调查分析综合医院住院患者焦虑抑郁状况[J].中国现代医药杂志, 2017,19(3):47-49. DOI:10.3969/j.issn.1672-9463.2017.03.013. [10] Mehnert A, Herschbach P, Berg P, et al.Fear of progression in breast cancer patients-validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)[J]. Z Psychosom Med Psychother, 2006,52(3):274-288. DOI: 10.13109/zptm.2006.52.3.274. [11] 吴奇云, 叶志霞, 李丽, 等. 癌症患者恐惧疾病进展简化量表的汉化及信效度分析[J]. 中华护理杂志, 2015,50(12):1515-1519. DOI:10.3761/j.issn.0254-1769.2015.12.021. [12] Zimet GD, Powell SS, Farley GK, et al.Psychometric characteristics of the Multidimensional Scale of Perceived Social Support[J]. J Pers Assess, 1990, 55(3/4): 610-617. DOI: 10.1080/00223891.1990.9674095. [13] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249. DOI: 10.3322/caac.21660. [14] 姜华, 吕俭霞, 牟文轩, 等. 中国鼻咽癌患者抑郁症状发生率的Meta分析[J].广州医科大学学报, 2021,49(6):18-25. DOI:10.3969/j.issn.2095-9664.2021.06.04. [15] Pinquart M, Duberstein PR.Depression and cancer mortality: a Meta-analysis[J]. Psychol Med, 2010, 40(11):1797-1810. DOI: 10.1017/S0033291709992285. [16] Granek L, Nakash O, Ben-David M, et al.Oncologists' treatment responses to mental health distress in their cancer patients[J]. Qual Health Res, 2018,28(11):1735-1745. DOI: 10.1177/1049732318786479. [17] Li R, Su L, Hua Y, et al.Anxiety and depression status prior to radiotherapy in patients with nasopharyngeal carcinoma and its effect on acute radiation toxicities[J]. Eur J Cancer Care (Engl), 2021,30(6):e13487. DOI: 10.1111/ecc.13487. [18] 王乾沙, 魏清风, 钟清玲, 等. 肺癌患者癌症复发恐惧现状及影响因素研究[J].中国护理管理, 2020,20(10):1596-1600. DOI:10.3969/j.issn.1672-1756.2020.10.034. [19] Kulpa M, Zietalewicz U, Kosowicz M, et al.Anxiety and depression and cognitive coping strategies and health locus of control in patients with ovary and uterus cancer during anticancer therapy[J]. Contemp Oncol (Pozn), 2016,20(2):171-175. DOI: 10.5114/wo.2016.60074. [20] Hanprasertpong J, Geater A, Jiamset I, et al.Fear of cancer recurrence and its predictors among cervical cancer survivors[J]. J Gynecol Oncol, 2017,28(6):e72. DOI: 10.3802/jgo.2017.28.e72. [21] 王盼盼, 从恩朝, 罗斌, 等. 肿瘤相关性抑郁焦虑的研究进展[J]. 现代肿瘤医学, 2023,31(15):2922-2925. DOI:10.3969/j.issn.1672-4992.2023.15.030. [22] Podina IR, Todea D, Fodor LA.Fear of cancer recurrence and mental health: a comprehensive Meta-analysis[J]. Psychooncology, 2023,32(10):1503-1513. DOI: 10.1002/pon.6205. [23] 郭婷婷, 邢伟, 张苇, 等. 郑州市某三甲医院中青年妇科癌症患者恐惧疾病进展现状及影响因素分析[J]. 现代预防医学, 2019,46(14):2607-2611. [24] 崔静萍,蒋燕,赵姗姗.衰弱和抑郁在肺癌化疗患者恐惧疾病进展与生活质量间的链式中介作用[J].护理学报,2023,30(18):65-70.DOI:10.16460/j.issn1008-9969.2023.18.065. [25] Dankert A, Duran G, Engst-Hastreiter U, et al.Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis[J]. Rehabilitation (Stuttg), 2003,42(3):155-163. DOI: 10.1055/s-2003-40094. [26] Mutsaers B, Butow P, Dinkel A, et al.Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study[J]. Psychooncology, 2020,29(2):430-436. DOI:10.1002/pon.5283. [27] Koch L, Bertram H, Eberle A, et al.Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship-a multi-regional population-based study[J]. Psychooncology, 2014,23(5):547-554.DOI:10.1002/pon.3452. |
|